pulmonary fibrosis/edema

SEQUENCE LISTING The instant application contains a Sequence Listing, which is entitled QUARK0005US_SeqListing.txt, created on Aug. 30, 2013 and 2280 kb in size, and is hereby incorporated by reference in its entirety. Throughout this application various patents and publications are cited. The

SEQUENCE LISTING The instant application contains a Sequence Listing, which is entitled 115340_22802_sequence listing 28OCT15.txt, submitted on Oct. 28, 2015 and 2,279.79 kb in size and is hereby incorporated by reference in its entirety. Throughout this application various patents and publications

TECHNICAL FIELD This invention relates to methods of preventing or treating diseases or conditions of the lung associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema. Particularly, this invention relates to

FIELD OF THE INVENTION The present invention relates to methods of treating pulmonary disease using acetazolamide and structurally related derivatives. BACKGROUND OF THE INVENTION Alveolar hypoxia, as occurs with ascent to high altitude or chronic lung diseases, results in hypoxic pulmonary

BACKGROUND OF THE INVENTION Throughout this application various publications are referenced by numbers. The full citations are listed at the end of the specification immediately preceeding the claims. The proteinase-antiproteinase concept of emphysema has served to focus research on the role of